Here we will present new research findings, publish the latest news and report on other topics in the world of cannabinoids. We will of course also write about our operations and how the company is developing, among other things.
Due to the pandemic and the restrictions that still apply to gatherings and travel, we are unable to conduct the event as we would have liked. That is why we are canceling Cannabis in Focus, which would have been held at Berns Salonger in Stockholm on 1 October 2020.
We aim to carry out the event in April 2021 instead. More info to come …
Bedrocan is a world leader in GMP certified cultivation of medical cannabis with a very high quality of all its products. Therefore, Aureum Life and […]
Sweden’s first major international cannabis event “Cannabis in Focus” has now been cancelled by the organiser Aureum Life. Cancellation is due to the ongoing and […]
Seminar and Event/ Full day and evening Aureum Life invites for a full day focusing on cannabis. Featuring debates, lectures and information covering all aspects […]
Auresacculin will be ready for the Swedish market within 18 months. Pharma company Aureum Life expects the research and development work to be finished in 6–8 months.
Aureum Life is launching its website today. Among other things, it presents the company’s ambitious plans for medical cannabis on the Swedish market, along with several upcoming facilities.
Christian Engström
+46 (0)70-663 37 80
christian.engstrom@aureumlife.se